Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VitalCopper is a dietary supplement designed to provide a highly bioavailable source of copper, primarily in the form of copper sebacate. As an essential trace mineral, copper is a fundamental component of several cuproenzymes that are critical for human health. It serves as a cofactor for cytochrome c oxidase, the terminal enzyme in the mitochondrial electron transport chain responsible for ATP production. Additionally, copper is a key constituent of superoxide dismutase (SOD), which protects cells from oxidative damage, and lysyl oxidase, which is essential for the cross-linking of collagen and elastin in the extracellular matrix. VitalCopper is utilized to support cardiovascular function, maintain healthy bone density, and promote the integrity of the nervous and immune systems, particularly in individuals with inadequate dietary intake or increased physiological demand for copper.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on VitalCopper.